The results of our study indicated that compared with before BPA, the levels of NT-proBNP, TNF-α as well as IL-6 were significantly lower in CTEPH patients 3 months after the last BPA. The gene discussed is NPPB; the disease is chronic thromboembolic pulmonary hypertension.